Immune suppression in renal cell carcinoma

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Tumor-infiltrating lymphocytes (TILs) possess anti-tumor activity, yet renal cell carcinomas (RCCs) often progress in vivo.
• The presence of TILs in situ suggests a potential immune response against RCC.
• The failure of the immune system to control RCC necessitates an investigation into inhibitory factors.

Purpose of the Study:

• To review the current understanding of suppressive mechanisms hindering anti-tumor immunity in RCC.
• To explore the complex host-tumor interactions that allow RCC progression.
• To highlight the implications for improving immunotherapy strategies in RCC.

Main Methods:

• Literature review of existing research on RCC immunology and immune evasion.
• Analysis of identified factors and pathways that inhibit innate and adaptive immune cells.
• Synthesis of current knowledge on suppressive mechanisms in the RCC tumor microenvironment.

Main Results:

• A complex interplay of factors and pathways actively suppresses effector immune cells within the RCC microenvironment.
• These suppressive mechanisms effectively neutralize the anti-tumor activity of TILs.
• The immune system's ability to control RCC is compromised by these multifaceted inhibitory processes.

Conclusions:

• Understanding the intricate mechanisms of immune suppression in RCC is crucial.
• Knowledge of host-tumor interactions can guide the development of more effective immunotherapies.
• Targeting these suppressive pathways holds promise for enhancing cytokine therapy and other immunotherapeutic approaches for RCC.